Home › Funds › ACUTA CAPITAL PARTNERS, LLC › LBRX

ACUTA CAPITAL PARTNERS, LLC position in LBRX

LB PHARMACEUTICALS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 52,718 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.60% of its reported portfolio and ranking #17 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)52.72K sh
Reported value held$2.02M
Portfolio Weight1.60%
First reportedQ3 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's LBRX position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in LBRX in Q3 2025 at 30,000 shares (US$474K). The position peaked in Q3 2026 at 52,718 shares, worth US$2.0M. Across 5 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 52,718 shares valued at US$2.0M — an increase of 23,799 shares quarter over quarter.. Notable position changes include a 82% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 30.00K $473.70K New
Q4 2025 30.00K $667.80K Hold
Q1 2026 28.92K $713.14K Reduce
Q2 2026 28.92K $938.57K Hold
Q3 2026 52.72K $2.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 107 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$128.7M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held LBRX?

ACUTA CAPITAL PARTNERS, LLC has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is ACUTA CAPITAL PARTNERS, LLC's current position in LBRX?

As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 52.72K shares of LBRX (LB PHARMACEUTICALS INC), valued at $2.02M, representing 1.60% of its reported portfolio and ranking #17.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling LBRX?

In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC increased its position in LBRX. The position peaked in Q3 2026 at 52.72K shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 107 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.